These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9001834)

  • 81. [Double-blind study on therapy with new drugs in stomach and duodenal ulcers].
    Klincewicz H; Hasik J; Hryniewiecki L
    Dtsch Z Verdau Stoffwechselkr; 1983; 43(1):22-6. PubMed ID: 6301804
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Ulcer recurrence following duodenal ulcer healing with omeprazole, ranitidine, or placebo: a double-blind, multicenter, 6-month study. The Omeprazole Duodenal Ulcer Study Group.
    Graham DY; Colon-Pagan J; Morse RS; Johnson TL; Walsh JH; McCullough AJ; Marks JW; Sklar M; Stone RC; Cagliola AJ
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1289-94. PubMed ID: 1551535
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Ranitidine in the treatment of gastric and duodenal ulcers associated with non-steroidal anti-inflammatory drugs.
    Tildesley G; Ehsanullah RS; Wood JR
    Br J Rheumatol; 1993 Jun; 32(6):474-8. PubMed ID: 8508283
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Pantoprazole versus ranitidine in the treatment of duodenal ulcer: a multicenter study in Brazil.
    Meneghelli UG; Zaterka S; de Paula Castro L; Malafaia O; Lyra LG
    Am J Gastroenterol; 2000 Jan; 95(1):62-6. PubMed ID: 10638560
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Symptomatic recurrence of healed duodenal and prepyloric ulcers after treatment with ranitidine or high-dose antacid. A 1-year follow-up study.
    Bytzer P; Lauritsen K; Rask-Madsen J
    Scand J Gastroenterol; 1986 Aug; 21(6):765-8. PubMed ID: 3749811
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Ranitidine 150 mg twice daily vs 300 mg nightly in treatment of duodenal ulcers.
    Ireland A; Colin-Jones DG; Gear P; Golding PL; Ramage JK; Williams JG; Leicester RJ; Smith CL; Ross G; Bamforth J
    Lancet; 1984 Aug; 2(8397):274-6. PubMed ID: 6146821
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Treatment of gastric ulcer with ranitidine.
    Schulz TB; Berstad A; Rydning A; Frislid K
    Scand J Gastroenterol; 1984 Jan; 19(1):119-21. PubMed ID: 6324332
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Acid suppression therapy is not required after one-week anti-Helicobacter pylori triple therapy for duodenal ulcer healing].
    Dupas JL; Corallo J; Helbert T; Zaïm M
    Gastroenterol Clin Biol; 2000; 24(6-7):638-43. PubMed ID: 10962387
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Does Caved-S decrease the gastric ulcer relapse rate during maintenance treatment with ranitidine?
    Morgan AG; Pacsoo C; Taylor P; McAdam WA
    Aliment Pharmacol Ther; 1987 Dec; 1(6):633-8. PubMed ID: 2979691
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Ulcer healing and relapse prevention by ranitidine in peptic ulcer disease.
    Liedberg G; Davies HJ; Enskog L; Eriksson S; Frederiksen B; Graffner H; Hradsky M; Oscarson J; Rydberg B; Simert G
    Scand J Gastroenterol; 1985 Oct; 20(8):941-4. PubMed ID: 3909374
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Acute treatment of duodenal ulcer: a multicentre study to compare ranitidine 150 mg twice daily with ranitidine 300 mg once at night.
    Lee FI; Reed PI; Crowe JP; McIsaac RL; Wood JR
    Gut; 1986 Sep; 27(9):1091-5. PubMed ID: 3530897
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Lansoprazole versus ranitidine in the prevention of early recurrences of digestive hemorrhages from gastroduodenal ulcers. Randomized double-blind multicenter study].
    Michel P; Duhamel C; Bazin B; Raoul JL; Person B; Bigard MA; Legoux JL; Sallerin V; Colin R
    Gastroenterol Clin Biol; 1994; 18(12):1102-5. PubMed ID: 7750682
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Comparison of once daily doses of lansoprazole (15, 30, and 60 mg) and placebo in patients with gastric ulcer.
    Avner DL; Movva R; Nelson KJ; McFarland M; Berry W; Erfling W
    Am J Gastroenterol; 1995 Aug; 90(8):1289-94. PubMed ID: 7639232
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Rabeprazole: a review of its use in acid-related gastrointestinal disorders.
    Langtry HD; Markham A
    Drugs; 1999 Oct; 58(4):725-42. PubMed ID: 10551440
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Efficacy and safety of rioprostil, 300 micrograms b.d., in the treatment of gastric ulcer: a comparison vs. ranitidine, 150 mg b.d., in a randomized multicentre study.
    Rutgeerts P; Vantrappen G; Businger JA; Demol P; Simon B; Barbier P
    Scand J Gastroenterol Suppl; 1989; 164():184-90. PubMed ID: 2510265
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial. Gastrointestinal Utilization Trial Study Group.
    Sonnenberg A; Schwartz JS; Cutler AF; Vakil N; Bloom BS
    Arch Intern Med; 1998 Apr; 158(8):852-60. PubMed ID: 9570170
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Nonprescription doses of ranitidine are effective in the relief of episodic heartburn.
    Ciociola AA; Pappa KA; Sirgo MA
    Am J Ther; 2001; 8(6):399-408. PubMed ID: 11704778
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Nine years of maintenance treatment with ranitidine for patients with duodenal ulcer disease.
    Penston JG; Wormsley KG
    Aliment Pharmacol Ther; 1992 Oct; 6(5):629-45. PubMed ID: 1420753
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Once-Daily Bedtime Dose of Roxatidine and Ranitidine in Acute Duodenal Ulcer: A Combined Assessment of Acid Inhibitory Activity and Healing Rate.
    Savarino V; Mela GS; Zentilin P; Mele MR; Vigneri S; Termini R; Di Mario F; Ferrana M; Malesci A; Belicchi M
    Am J Ther; 1995 Dec; 2(12):949-953. PubMed ID: 11854813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.